| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
19 companies
Cormorant Asset Management, LP serves as a Former 10% Owner at EYPT and has filed Form 4s across 19 companies. Across recent SEC filings that breaks down to 81 buys and 18 sells. Those positions are worth an estimated $572.1M at current prices.
Historically, Cormorant Asset Management, LP's trades have earned a below-average insider score of 49/100 across 30 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -31.1%.
The biggest single holding is EYPT (~$129.8M). Net of sales, the recent Form 4 record there shows accumulation of 4,734,057 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | DRUG Bright Minds Biosciences Inc. | Former 10% Owner | Sell | 109,331 | $89.50 | $9,785,124.50 | -10.3% | -19.2% | - | |
| Dec 11, 2025 | CRBP Corbus Pharmaceuticals Holdings, Inc. | - | Sell | 30,029 | $11.46 | $344,012.22 | -1.3% | +7.7% | - | |
| Dec 4, 2025 | EYPT Eyepoint, Inc. | - | Sell | 60,000 | $15.70 | $942,240.00 | -0.7% | +7.7% | - | |
| May 15, 2025 | OKUR Onkure Therapeutics, Inc. | - | Sell | 1,813,439 | $1.85 | $3,363,022.63 | -100% | +16.5% | +53.4% | |
| May 12, 2025 | OKUR Onkure Therapeutics, Inc. | - | Sell | 24,300 | $1.99 | $48,235.50 | -1.3% | +4.1% | +73.8% | |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | - | Buy | 187,500 | $16.00 | $3,000,000.00 | +23.4% | -31.7% | -9.0% | |
| Nov 4, 2024 | DRUG Bright Minds Biosciences Inc. | - | Buy | 184,331 | $21.70 | $3,999,982.70 | +21.1% | -26.4% | +1.4% | |
| Oct 16, 2024 | DRUG Bright Minds Biosciences Inc. | - | Buy | 422,591 | $7.65 | $3,234,386.83 | +93.4% | +22.4% | +130.6% | |
| Sep 27, 2024 | BIOA Bioage Labs, Inc. | - | Buy | 450,000 | $18.00 | $8,100,000.00 | +38.2% | -72.0% | -74.2% | |
| Sep 20, 2024 | CRBP Corbus Pharmaceuticals Holdings, Inc. | - | Buy | 350,000 | $20.01 | $7,003,760.61 | +17.3% | -31.7% | -41.1% |